barrett's esophagus Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New/Updated Trials
Online Trials
Languages supported at study center
Age Group

Male only (49)
Female only (107)
Transgender (1)
Non-Binary (3)
Any (1156)

Phase 0 (3)
Phase 1 (90)
Phase 1/2 (54)
Phase 2 (115)
Phase 2/3 (16)
Phase 3 (60)
Phase 3/4 (1)
Phase 4 (29)
Unknown (947)

Interventional (756)
Observational (532)
INTERVENTIONAL (3)

Sanofi (20)
Second Affiliated Hospital, School of Medicine, Zhejiang University (11)
Chinese University of Hong Kong (9)
Eli Lilly and Company (9)
University Hospital, Montpellier (9)
Shenzhen Geno-Immune Medical Institute (8)
Massachusetts General Hospital (7)
NYU Langone Health (7)
Oslo University Hospital (7)
Sun Yat-sen University (7)
AstraZeneca (6)
Children's Hospital Medical Center, Cincinnati (6)
Sanofi Pasteur, a Sanofi Company (6)
University Hospital Inselspital, Berne (6)
University Hospital, Basel, Switzerland (6)
University of Pennsylvania (6)
University of Washington (6)
Columbia University (5)
Dana-Farber Cancer Institute (5)
Hospices Civils de Lyon (5)
National Cancer Institute (NCI) (5)
Peking University Third Hospital (5)
Seoul National University Hospital (5)
The First Affiliated Hospital of Zhengzhou University (5)
University of Colorado, Denver (5)
University of Pittsburgh (5)
AbbVie (4)
Aretaieion University Hospital (4)
Assistance Publique - Hôpitaux de Paris (4)
Cairo University (4)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (4)
Gustave Roussy, Cancer Campus, Grand Paris (4)
Hoffmann-La Roche (4)
Indiana University (4)
Istituto Clinico Humanitas (4)
Johns Hopkins University (4)
M.D. Anderson Cancer Center (4)
Mayo Clinic (4)
Memorial Sloan Kettering Cancer Center (4)
Radboud University (4)
Royal Marsden NHS Foundation Trust (4)
Shanghai Jiao Tong University School of Medicine (4)
Stanford University (4)
Sunnybrook Health Sciences Centre (4)
The Netherlands Cancer Institute (4)
The University of Hong Kong (4)
University Hospital, Ghent (4)
University of Aarhus (4)
University of California, San Francisco (4)
University of Chicago (4)
University of Malaya (4)
University of Michigan (4)
University of Sao Paulo (4)
Washington University School of Medicine (4)
Weill Medical College of Cornell University (4)
Yale University (4)
Abbott Medical Devices (3)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (3)
Bayer (3)
Damanhour University (3)
Duke University (3)
Eko Devices, Inc. (3)
Genzyme, a Sanofi Company (3)
Hacettepe University (3)
He Huang (3)
Icahn School of Medicine at Mount Sinai (3)
Imperial College London (3)
Institut National de la Santé Et de la Recherche Médicale, France (3)
Institut du Cancer de Montpellier - Val d'Aurelle (3)
Institute of Hematology & Blood Diseases Hospital (3)
Jonsson Comprehensive Cancer Center (3)
Karolinska University Hospital (3)
Manchester University NHS Foundation Trust (3)
Merck Sharp & Dohme Corp. (3)
National Cancer Institute, Naples (3)
National Heart, Lung, and Blood Institute (NHLBI) (3)
National Institute of Allergy and Infectious Diseases (NIAID) (3)
National Institute of Neurological Disorders and Stroke (NINDS) (3)
National Taiwan University Hospital (3)
Novartis Pharmaceuticals (3)
Sahlgrenska University Hospital, Sweden (3)
Taipei Medical University (3)
The University of Texas Health Science Center, Houston (3)
Universitair Ziekenhuis Brussel (3)
Universitaire Ziekenhuizen Leuven (3)
University Health Network, Toronto (3)
University Hospital, Bordeaux (3)
University Hospital, Grenoble (3)
University Hospital, Toulouse (3)
University of California, Davis (3)
University of California, San Diego (3)
University of Illinois at Chicago (3)
University of Leicester (3)
University of Milano Bicocca (3)
University of Nottingham (3)
University of Texas Southwestern Medical Center (3)
University of Wisconsin, Madison (3)
University of Zurich (3)
Uppsala University (3)
VA Pittsburgh Healthcare System (3)

No (981)
Yes (335)

Updated trials (3)

No (1316)

English (6)
Argentinian Spanish (5)
All Languages (4)
Armenian (3)
Australian English (3)
Asturian (2)
Spanish (2)
Bengali (1)
British English (1)
Chinese (1)
Colombian Spanish (1)
French (1)
Hindi (1)

Adult (18+) (1237)
Pediatric (Under 18) (312)

I am/have/had

I am/have/hadcancer

I am/have/hadEGFR

I am/have/hadHER2

I am/have/hadadenocarcinoma

I am/have/hadplatelet count

I am/have/hadabsolute neutrophil count

I am/have/hadhysterectomy

I am/have/hadcough

I am/have/hadmetastasis

I am/have/hadct scan

I am/have/hadcarcinoma

I am/have/hadsquamous cell carcinoma

I am/have/hadlung cancer

I am/have/hadhypertension

I am/have/hadserum pregnancy test

I am/have/hadblood test

I am/have/hadlymphoma

I am/have/hadinfarct

I am/have/hadpulmonary function test

I am/have/hadserum bilirubin level

added new label for I am/have/had

I am looking for

I am looking forprobe

I am looking forcetuximab

I am looking foranticoagulants

I am looking forvegf

I am looking forinsulin

I am looking forbevacizumab

I am looking fortyrosine

I am looking formonoclonal protein

I am looking forher-2

I am looking forlocal anesthesia

I am looking forcapecitabine

I am looking forfludarabine

I am looking forhydroxychloroquine

I am looking forpaclitaxel

I am looking forplatinum-based chemotherapy

I am looking forprednisone

I am looking fornitrosoureas

I am looking forhuman chorionic gonadotropin

I am looking foropioid

I am looking fordocetaxel

added new label for I am looking for

Advanced Filters

Found 1305 clinical trials

For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Endocrinology
Recruiting

SBRT Versus Ablation for Perivascular Hepatocellular Carcinoma

This trial is a multi-center, phase III, randomized (1:1) clinical trial. The aim is to explore the efficacy and safety of SBRT for perivascular hepatocellular carcinoma, compared with RFA.

radiofrequency ablation

recurrent hepatocellular carcinoma

carcinoma

hepatocellular carcinoma

stereotactic body radiation therapy

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Moxibustion Plus Cupping in Convalescent Patients With COVID-19

This trial is designed to evaluate the efficacy and safety of moxibustion plus cupping in the convalescence of COVID-19.

oximetry

cough

dyspnea

asthenia

convalescence

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Use of Safety Behaviors in Exposure Therapy for Arachnophobia

This study examines the impact of safety behaviors (i.e., unnecessary protective actions) on outcomes of exposure therapy for spider phobia. Researchers will compare exposure therapy with (a) no safety behaviors, (b) safety behaviors faded toward the end of treatment, and (c) unfaded safety behaviors.

exposure therapy

arachnophobia

phobia

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients

The purpose of this study assess the efficacy and safety of anti-SARS-CoV-2 convalescent plasma in hospitalized patients with acute respiratory symptoms up to 14 days after the onset of initial symptoms.

acute respiratory syndrome (sars)

SARS

coronavirus infection

respiratory symptom

covid-19

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort

Comparison of the effects of CYT107 vs Placebo administered IM at 10g/ kg twice a week for two weeks on immune reconstitution of lymphopenic COVID-19 patients.

absolute lymphocyte count

corticosteroids

interleukin-7

intermittent positive pressure ventilation

invasive positive pressure ventilation

0 views
19 Feb, 2024

Phase 2
For pediatric ages
For Seniors
Recruiting in 100s
Interventional Study
all
Recruiting

A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection

Purpose of Study The purpose of this study to evaluate, the effectiveness of convalescent plasma in combatting the symptoms and effects of the coronavirus disease, COVID-19. Beyond supportive care, there are no proven treatment options for COVID-19.

acute respiratory syndrome (sars)

coronavirus infection

SARS

fraction of inspired oxygen (fio2)

oxygen saturation

0 views
19 Feb, 2024

Phase 1
For pediatric ages
For Seniors
Recruiting in 100s
Interventional Study
all
Recruiting

Safety and Effectiveness of the PXL-Platinum 330 System

To evaluate the safety and effectiveness of the PXL Platinum 330 system for performing corneal cross-linking (CXL) for the treatment of ectatic disorders.

radial keratotomy

riboflavin

terrien's marginal degeneration

keratoconus

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Effect of Ketone Esters in Parkinson's Disease

Ketones esters have shown to improve mitochondrial function and are currently use to enhanced functional performance. As Mitochondrial dysfunction is one of the proposed mechanism of neuronal injury in Parkinson's disease, the study aims to assess the tolerability,side effects and effect of oral ketone esters in Patients with Parkinson's disease.

parkinson's disease

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Cardiovascular Diseases
Recruiting

VitaFlow II Transcatheter Aortic Valve System Pre-market Trial

This is a pre-market clinical investigation aiming to evaluate the safety and effectiveness of Microport CardioFlow VitaFlow II Transcatheter Aortic Valve System for the treatment of severe aortic stenosis.

stenosis

transcatheter aortic valve implantation

aortic stenosis

aortic valve replacement

0 views
19 Feb, 2024

For pediatric ages
For Seniors
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

A study of CT-RD06 cell injection in patients with relapsed or refractory CD19+ B-cell hematological malignancy.

lymphoma

diffuse large b-cell lymphoma

oxygen saturation

acute lymphoblastic leukemia

oximetry

0 views
19 Feb, 2024